This innovative approach aims to deliver deeper, more durable results across weight reduction, glycemic control, and overall metabolic health
To request a license for this guideline, please contact Keith Price at [email protected]
Such findings highlight epigenetic regulation as a promising avenue for identifying new therapeutic targets for addiction
Evidence note: The candid clinician's position is to hold both truths at once
This review integrates current evidence on how brain peptides contribute to AD pathophysiology, summarizes recent progress in peptide-based therapeutic strategies and delivery platforms, and critically examines the remaining barriers to clinical translation, including bloodbrain barrier penetration, metabolic stability, off-target effects, and the need for biomarker-guided patient stratification
In addition, sensitivity analyses were conducted based on obesity and gender difference